These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1329642)

  • 1. Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates.
    Gooding BB; Erwin ME; Barrett MS; Johnson DM; Jones RN
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2049-50. PubMed ID: 1329642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation.
    Marco F; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 1997 Sep; 29(1):55-7. PubMed ID: 9350417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.
    Croco MA; Biedenbach DJ; Pfaller MA; Doern GV; Jones RN
    J Antimicrob Chemother; 1998 Nov; 42(5):672-3. PubMed ID: 9848457
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.
    Dubois J; Joly JR
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):89S-91S. PubMed ID: 2791504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
    Dubois J; St-Pierre C
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activities of sparfloxacin in Legionella infections.
    Saito A; Gaja M
    Drugs; 1995; 49 Suppl 2():250-2. PubMed ID: 8549320
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains.
    Edelstein PH; Gaudet EA; Edelstein MA
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):93S-95S. PubMed ID: 2791505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Ren J; Polzer R; Gladue RP
    Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
    Edelstein PH; Shinzato T; Edelstein MA
    J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages.
    Walz A; Nichterlein T; Hof H
    Zentralbl Bakteriol; 1997 Feb; 285(3):431-9. PubMed ID: 9084116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila.
    Jonas D; Engels I; Friedhoff C; Spitzmüller B; Daschner FD; Frank U
    J Antimicrob Chemother; 2001 Feb; 47(2):147-52. PubMed ID: 11157897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1992 Apr; 36(4):856-9. PubMed ID: 1323956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of ninety-eight clinical isolates of Legionella to macrolides and quinolones using the Etest.
    Schrock J; Hackman BA; Plouffe JF
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):221-3. PubMed ID: 9327252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
    Stout JE; Sens K; Mietzner S; Obman A; Yu VL
    Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Shinzato T; Doyle E; Edelstein MA
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2132-6. PubMed ID: 2619277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.